JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
ViewAll

Cover and Contents

Full Issue

: 115 : 55

Citation : Ünal S, Yağcı AM. The investigation of janus kinase 2 and calreticulin mutations in patients with essential thrombocytosis. J Curr Hematol Oncol Res. 2024;2(3):54-58.

Original Article - Hematology

Causes of acquired isolated neutropenia in adulthood: a single center study

: 177 : 84

Citation : Keklik M, Mert Yüce M, Akyol G, Mandacı Şanlı N, Çelik S, Eser B. Causes of acquired isolated neutropenia in adulthood: a single center study.J Curr Hematol Oncol Res. 2024;2(3):59-62.

Original Article - Hematology

: 234 : 73

Citation : Akyol G, Keklik M, Kaynar L, Ünal A. Follow-up of patients given isoniazid prophylaxis in multiple myeloma patients underwent autologous stem cell transplantation. J Curr Hematol Oncol Res. 2024;2(3):63-66.

Original Article - Hematology

The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience

: 228 : 59

Citation : Çelik S, Erkurt MA, Sarıcı A. The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience. J Curr Hematol Oncol Res. 2024;2(3):67-71.

Review - Hematology

: 306 : 77

Citation : Tan T, Ağırbaşlı M. Current status and potential future of PAI-1 inhibitors. J Curr Hematol Oncol Res. 2024;2(3): 72-75.

: 91 : 73

Citation : Aksöz Z. A case report of relapsed/refractory primary central nervous system lymphoma. J Curr Hematol Oncol Res. 2024; 2(3):76-78.
_Footer